Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of loteprednol etabonate ophthalmic
base, compared to loteprednol etabonate ophthalmic suspension, and vehicle in the prevention
of the signs and symptoms of allergic conjunctivitis in a modified Conjunctival Allergen
Challenge model and in an environmental model during pollen season. Comparisons will be made
following 2 weeks of dosing.